Averica Award for Supercritical Fluid Chromatography Announced
News Jul 15, 2013
“We are delighted that the first recipient of the Averica Award is Bill Farrell, who with his team at Pfizer has been central in helping to make SFC such a powerful technology,” noted Dr. Kiplinger. “Bill has had a substantial impact on the design of preparative SFC systems, including his critical contributions to stationary phase development, and he has played a major influential role at relevant scientific meetings. At Averica Discovery, we rely on preparative SFC to provide our customers a scalable approach to chromatographic isolation on an accelerated timescale, giving us the opportunity to appreciate Bill’s contributions to the field daily.”
SFC is used for the analysis and purification of low to moderate molecular weight molecules and for chiral separations. Carbon dioxide-based SFC achieves high resolution, yet is faster and more efficient than liquid-based HPLC. Importantly, SFC eliminates the need for organic chemical solvents and recycles CO2, making it an environmentally conscious, “greener” alternative. The increasingly prominent role of SFC technology is evidenced by the fact that the number of SFC-related articles in chromatography journals has risen 4-5 fold over the past decade.
Mr. Farrell commented, "This is really an honor. I've been lucky to work with colleagues and collaborators who contributed a passion for science and chromatography to many different projects, and I'm especially grateful that the body of our work is being recognized as a whole." As part of the Averica Award, Mr. Farrell received an honorarium and will deliver a keynote presentation at the SFC 2013 conference today.
The Averica Award is given annually at the International Conference on Packed Column SFC organized by the Green Chemistry Group. Recipients are chosen from submitted nominees, based on the novelty and impact of their work in the field of preparative SFC.
Separately, Averica Discovery Services announced that it will be moving to a larger facility at the end of the month. The new facility, located at 260 Cedar Hill Street, Marlborough, MA, 01752, essentially doubles the company’s space.
Dr. Kiplinger added, “We are proud that our commitment to providing exceptional, technologically advanced services has enabled us to double our business over the past year. We look forward to further strong growth based in our new facilities. And now we're even closer to our many customers in the greater Boston life sciences community.”
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE
Researchers Discover Key Link Between Mitochondria and Cocaine AddictionNews
Researchers were able to block response in mitochondria to cocaine.READ MORE
A Greener Way to Make KetonesNews
Researchers at McGill University have discovered a new, more environmentally friendly way to make ketones, an important chemical ingredient in pharmaceuticals. While ketones are found in a wide range of useful chemicals, they are commonly prepared through energy-intensive, multi-step technologies that create significant chemical waste.READ MORE